ARCHIVES

Caplan: NEJM Should Go “The Extra Moral Mile”

This article is from The Cancer Letter archive.

Vol. 35 No. 01 | January 9, 2009

Download PDF Visit The Full Archive

Related Articles

Herceptin Regimen Minus Adriamycin Increases Survival With Less Toxicity

October 28, 2011

NCI To End CIS Partnership Program In 2010.

December 5, 2008

In Brief: Cancer Panel To Meet In Seattle, Houston, Chicago; Wisconsin’s Robert Johnson Dies; Goldin Retires

August 27, 1982

ACS Funds Pilot Study Of Mammography Trial

July 28, 1995

Two Studies Demonstrate Molecule Blocking Cell Damage

August 26, 2011

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

July 26, 2013